# Stereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate Cancer

> **NCT02339701** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 68 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** IMRT
- **RADIATION:** SBRT

## Key facts

- **NCT ID:** NCT02339701
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-01-07
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02339701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02339701, "Stereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02339701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*